Vedana Therapeutics
Updated: August 07, 2026
Founders: Leon Garcia, Anurag Agarwal, Ernesto Aycardi
Country: USA | Funding: $46M (+)
Founded: 2024
Website: https://vedanatx.com/
Vedana Therapeutics is developing next-generation antibody therapies for migraine prevention. The biotech’s lead program is an anti-PACAP antibody, while its second program is a bispecific antibody targeting both PACAP and CGRP that is designed to treat patients who have not found relief with monotherapies. CGRP is a messenger protein in the nervous system that is released in excess during a migraine attack, causing blood vessels in the brain's outer lining to dilate and triggering severe inflammation and pain. PACAP is a neuropeptide that widens blood vessels and transmits pain signals.
Founded: 2024
Website: https://vedanatx.com/
Vedana Therapeutics is developing next-generation antibody therapies for migraine prevention. The biotech’s lead program is an anti-PACAP antibody, while its second program is a bispecific antibody targeting both PACAP and CGRP that is designed to treat patients who have not found relief with monotherapies. CGRP is a messenger protein in the nervous system that is released in excess during a migraine attack, causing blood vessels in the brain's outer lining to dilate and triggering severe inflammation and pain. PACAP is a neuropeptide that widens blood vessels and transmits pain signals.
